Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis.
Purity:
>99.0%
CAS Number:
[909395-70-6]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted